EVAN GOODMAN: Open Payments
NPI 1841685120 · CARLSBAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,594 in 42 payments from 11 companies in 2025. Trend: 2023 $1,114 · 2024 $1,794 · 2025 $1,594
Food & beverage: $1,594
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 12 | $510 |
| Boston Scientific Corporation | 8 | $342 |
| Saluda Medical Americas, Inc. | 5 | $293 |
| Averitas Pharma Inc. | 4 | $112 |
| Globus Medical, Inc. | 2 | $106 |
| SPR Therapeutics, Inc | 5 | $105 |
| Nalu Medical, Inc. | 2 | $38 |
| IBSA Pharma Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: SYNCHROMEDII, Evoke, WaveWriter Alpha Prime 16, QUTENZA, SPRINT PNS System, Vyrsa V1, Intracept, Nalu Neurostimulation System.
Industry payments across CA — which companies pay providers there.
